Search - tctmd.com

Displaying 441 - 460 of 1074

Sort: Relevancy | Date

News Daily News

TAVR Growing in the US, but Vast Majority of Patients Not Receiving Any Form of Valve Replacement

Michael O'Riordan

June 12, 2019

News Daily News

TAVR in End-stage Renal Disease: Increased Risk Highlights Research Gaps

Yael L. Maxwell

June 11, 2019

News Daily News

Similar Mortality, Higher Early Stroke Risks in TAVR for Bicuspid Aortic Stenosis

Michael O'Riordan

June 11, 2019

News Conference News EAS 2019

Should Lp(a) Be Measured and Treated? Two Experts Hash Out Its Current Role

Michael O'Riordan

June 07, 2019

News Conference News SCAI 2019

ProGlide Comes Out Ahead of Prostar in Vascular Closure After Transfemoral TAVR: BRAVO 3

Yael L. Maxwell

June 05, 2019

News Conference News EuroPCR 2019

Allegra TAVR System Feasible for Treating Degenerated Surgical Valves

Michael O'Riordan

May 29, 2019

CHOICE: Better Hemodynamics, Less Structural Deterioration with CoreValve

News Conference News EuroPCR 2019

Self-Expanding vs Balloon-Expandable TAVR? Some Insights From CHOICE

Michael O'Riordan

May 24, 2019

News Conference News EuroPCR 2019

TAVR’s Benefit Across ‘Spectrum of Risk’ Supports Paradigm Shifts, Says EuroPCR Statement

Shelley Wood

May 23, 2019

News Conference News EuroPCR 2019

Valve Leaflet Scoring Device for Aortic Stenosis Clears Feasibility Hurdle

Michael O'Riordan

May 23, 2019

News Conference News HRS 2019

PRAGUE-12: Surgical Ablation of A-fib During Cardiac Surgery Has Long-term Stroke Benefit

Todd Neale

May 20, 2019

News Conference News EuroPCR 2019

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

Shelley Wood

May 16, 2019

News Daily News

Public Comments Largely Supportive of CMS Plan for TAVR, With Some Suggested Tweaks

Todd Neale

May 01, 2019

News Industry News

Boston Scientific Receives FDA Approval for LOTUS Edge™ Aortic Valve System

April 23, 2019

News Daily News

Multisociety Consensus Statement Tackles the Classification of Heart Valve Centers

L.A. McKeown

April 19, 2019

News Daily News

Survival Better With Early AVR for Severe Asymptomatic Aortic Stenosis, Says Retrospective Study

L.A. McKeown

March 29, 2019

News Daily News

CMS Coverage Plan Keeps Volume Requirements for Existing TAVR Programs but Lowers Bar for New Centers

Michael O'Riordan

March 27, 2019

News Conference News EHRA 2019

Thromboembolic Risks High in Patients With A-fib, Valvular Disease

Todd Neale

March 25, 2019

News Conference News ACC 2019

TAVR in Bicuspid Aortic Stenosis Safe, Feasible in Selected Real-World Patients

Yael L. Maxwell

March 17, 2019

News Conference News ACC 2019

Low-Risk Trials Cement a Role for TAVR Alongside—or in Place of—Surgery

Michael O'Riordan

March 17, 2019

News Daily News

HF Admissions Decline, Non-CV Hospitalizations Rise After TAVR

L.A. McKeown

March 13, 2019

Advertisement

TAVR Growing in the US, but Vast Majority of Patients Not Receiving Any Form of Valve Replacement

TAVR in End-stage Renal Disease: Increased Risk Highlights Research Gaps

Similar Mortality, Higher Early Stroke Risks in TAVR for Bicuspid Aortic Stenosis

Should Lp(a) Be Measured and Treated? Two Experts Hash Out Its Current Role

ProGlide Comes Out Ahead of Prostar in Vascular Closure After Transfemoral TAVR: BRAVO 3

Allegra TAVR System Feasible for Treating Degenerated Surgical Valves

Self-Expanding vs Balloon-Expandable TAVR? Some Insights From CHOICE

TAVR’s Benefit Across ‘Spectrum of Risk’ Supports Paradigm Shifts, Says EuroPCR Statement

Valve Leaflet Scoring Device for Aortic Stenosis Clears Feasibility Hurdle

PRAGUE-12: Surgical Ablation of A-fib During Cardiac Surgery Has Long-term Stroke Benefit

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

Public Comments Largely Supportive of CMS Plan for TAVR, With Some Suggested Tweaks

Boston Scientific Receives FDA Approval for LOTUS Edge™ Aortic Valve System

Multisociety Consensus Statement Tackles the Classification of Heart Valve Centers

Survival Better With Early AVR for Severe Asymptomatic Aortic Stenosis, Says Retrospective Study

CMS Coverage Plan Keeps Volume Requirements for Existing TAVR Programs but Lowers Bar for New Centers

Thromboembolic Risks High in Patients With A-fib, Valvular Disease

TAVR in Bicuspid Aortic Stenosis Safe, Feasible in Selected Real-World Patients

Low-Risk Trials Cement a Role for TAVR Alongside—or in Place of—Surgery

HF Admissions Decline, Non-CV Hospitalizations Rise After TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content